Literature DB >> 24830877

Elephantiasic pretibial myxedema in a patient with graves disease that resolved after 131I treatment.

Haifang Yu1, Xue Jiang, Mingzhi Pan, Rui Huang.   

Abstract

Pretibial myxedema is a rare manifestation of Graves disease and is generally associated with ophthalmopathy. Steroids, immunoglobulin, or rituximab can have some therapeutic effect but not curative. Here we reported a 45-year-old man with history of hyperthyroidism for 20 years who developed severe bilateral pretibial myxedema. Three months after the treatment with I for his Graves disease, his pretibial myxedema was significantly improved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24830877     DOI: 10.1097/RLU.0000000000000459

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases.

Authors:  Changgui Lan; Yi Wang; Xia Zeng; Jing Zhao; Xiaoxi Zou
Journal:  J Thyroid Res       Date:  2016-08-25

2.  Treatment of pretibial myxedema with intralesional immunomodulating therapy.

Authors:  Ziwei Ren; Min He; Fang Deng; Yan Chen; Liyin Chai; Bing Chen; Wuquan Deng
Journal:  Ther Clin Risk Manag       Date:  2017-09-08       Impact factor: 2.423

3.  Edematous lower extremities with overlying verrucous plaques.

Authors:  Antonio Jimenez; Frank Winsett; Brent Kelly
Journal:  JAAD Case Rep       Date:  2020-12-10

4.  Pretibial Myxedema Presenting as Severe Elephantiasis.

Authors:  Jae-Hoon Lee; Sang-Myung Park; Bark-Lynn Lew; Woo-Young Sim
Journal:  Ann Dermatol       Date:  2018-08-28       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.